Skip to main content
Journal cover image

Prevalence and impact of medical comorbidity in Alzheimer's disease.

Publication ,  Journal Article
Doraiswamy, PM; Leon, J; Cummings, JL; Marin, D; Neumann, PJ
Published in: J Gerontol A Biol Sci Med Sci
March 2002

BACKGROUND: We examined the prevalence of comorbid medical illnesses in Alzheimer's disease (AD) patients at different severity levels. We also examined the effect of cumulative medical comorbidity on cognition and function. METHODS: Analyses of data from 679 AD patients (Mini-Mental State Exam score range 0-30, mean +/- SD = 11.8 +/- 8) from 13 sites (four dementia centers assessing outpatients, four managed care organizations, two assisted living facilities, and three nursing homes) prospectively recruited using a stratification approach including dementia severity and care setting. Medical comorbidity was quantified using the Cumulative Illness Rating Scale-Geriatric. RESULTS: Across patients, 61% had three or more comorbid medical illnesses. Adjusting for age, gender, race, and care setting, medical comorbidity increased with dementia severity (mild to moderate, p <.01; moderate to severe, p <.001). Adjusting for age, educational level, gender, race, and care setting, higher medical comorbidity was associated with greater impairment in cognition (p <.001) and in self-care (p <.001). CONCLUSIONS: Despite the limitation of a cross-sectional design, our initial findings suggest that there is a strong association between medical comorbidity and cognitive status in AD. Optimal management of medical illnesses may offer potential to improve cognition in AD.

Duke Scholars

Published In

J Gerontol A Biol Sci Med Sci

DOI

ISSN

1079-5006

Publication Date

March 2002

Volume

57

Issue

3

Start / End Page

M173 / M177

Location

United States

Related Subject Headings

  • Prevalence
  • Male
  • Humans
  • Gerontology
  • Female
  • Cross-Sectional Studies
  • Comorbidity
  • Cognition
  • Alzheimer Disease
  • Aged, 80 and over
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Doraiswamy, P. M., Leon, J., Cummings, J. L., Marin, D., & Neumann, P. J. (2002). Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci, 57(3), M173–M177. https://doi.org/10.1093/gerona/57.3.m173
Doraiswamy, P Murali, Joel Leon, Jeffrey L. Cummings, Deborah Marin, and Peter J. Neumann. “Prevalence and impact of medical comorbidity in Alzheimer's disease.J Gerontol A Biol Sci Med Sci 57, no. 3 (March 2002): M173–77. https://doi.org/10.1093/gerona/57.3.m173.
Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002 Mar;57(3):M173–7.
Doraiswamy, P. Murali, et al. “Prevalence and impact of medical comorbidity in Alzheimer's disease.J Gerontol A Biol Sci Med Sci, vol. 57, no. 3, Mar. 2002, pp. M173–77. Pubmed, doi:10.1093/gerona/57.3.m173.
Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002 Mar;57(3):M173–M177.
Journal cover image

Published In

J Gerontol A Biol Sci Med Sci

DOI

ISSN

1079-5006

Publication Date

March 2002

Volume

57

Issue

3

Start / End Page

M173 / M177

Location

United States

Related Subject Headings

  • Prevalence
  • Male
  • Humans
  • Gerontology
  • Female
  • Cross-Sectional Studies
  • Comorbidity
  • Cognition
  • Alzheimer Disease
  • Aged, 80 and over